Cargando…

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

BACKGROUND: Surveys and retrospective studies of patients with idiopathic pulmonary fibrosis (IPF) have shown a significant diagnostic delay. However, the causes and risk factors for this delay are not known. METHODS: Dates at six time points before the IPF diagnosis (onset of symptoms, first contac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoyer, Nils, Prior, Thomas Skovhus, Bendstrup, Elisabeth, Wilcke, Torgny, Shaker, Saher Burhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534848/ https://www.ncbi.nlm.nih.gov/pubmed/31126287 http://dx.doi.org/10.1186/s12931-019-1076-0

Ejemplares similares

Diagnostic delay in IPF impacts progression-free survival, quality of life and hospitalisation rates
por: Hoyer, Nils, et al.
Publicado: (2022)

Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2020)

Validation of the King’s Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis
por: Prior, Thomas Skovhus, et al.
Publicado: (2019)

Validation of the IPF-specific version of St. George’s Respiratory Questionnaire
por: Prior, Thomas Skovhus, et al.
Publicado: (2019)

Validation of a derived version of the IPF-specific Saint George’s Respiratory Questionnaire
por: Prior, Thomas Skovhus, et al.
Publicado: (2021)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment
por: Kølner-Augustson, Line, et al.
Publicado: (2020)

Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis
por: Jessen, Henrik, et al.
Publicado: (2021)

Validation of the COPD Assessment Test (CAT) in patients with idiopathic pulmonary fibrosis
por: Grufstedt, Heidi Kjeldgaard, et al.
Publicado: (2018)

Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis
por: Jessen, H., et al.
Publicado: (2021)

Economic consequences of idiopathic pulmonary fibrosis in Denmark
por: Hilberg, Ole, et al.
Publicado: (2018)

Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis
por: Brix, Ninna, et al.
Publicado: (2016)

Danish respiratory society position paper: palliative care in patients with chronic progressive non-malignant lung diseases
por: Marsaa, Kristoffer, et al.
Publicado: (2018)

Changes in management of idiopathic pulmonary fibrosis: impact on disease severity and mortality
por: Hyldgaard, Charlotte, et al.
Publicado: (2020)

Increased respiratory morbidity in individuals with interstitial lung abnormalities
por: Hoyer, Nils, et al.
Publicado: (2020)

PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
por: Kronborg-White, Sissel, et al.
Publicado: (2021)

Familial idiopathic pulmonary fibrosis in a young female
por: Sritharan, Sajitha S., et al.
Publicado: (2018)

Chest x-ray findings in tuberculosis patients identified by passive and active case finding: A retrospective study
por: Rastoder, Ema, et al.
Publicado: (2019)

Global incidence and prevalence of idiopathic pulmonary fibrosis
por: Maher, Toby M., et al.
Publicado: (2021)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians
por: Bendstrup, Elisabeth, et al.
Publicado: (2019)

Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data
por: Knarborg, Malene, et al.
Publicado: (2023)

Rituximab-induced interstitial lung disease: five case reports
por: Naqibullah, Matiuallah, et al.
Publicado: (2015)

Tele-Rehabilitation Program in Idiopathic Pulmonary Fibrosis—A Single-Center Randomized Trial
por: Cerdán-de-las-Heras, Jose, et al.
Publicado: (2021)

Organisation of diagnosis and treatment of idiopathic pulmonary fibrosis and other interstitial lung diseases in the Nordic countries
por: Bendstrup, Elisabeth, et al.
Publicado: (2015)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome
por: Bordas-Martínez, Jaume, et al.
Publicado: (2021)

Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Potential Delays in Diagnosis of Idiopathic Pulmonary Fibrosis in Medicare Beneficiaries
por: Mooney, Joshua, et al.
Publicado: (2019)

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation
por: Maher, Toby M., et al.
Publicado: (2019)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis and occupational risk factors
por: Ranzieri, Silvia, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis
por: Kakugawa, Tomoyuki, et al.
Publicado: (2016)

The effect of the walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis: a feasibility study
por: Wapenaar, Monique, et al.
Publicado: (2020)

Idiopathic and immune‐related pulmonary fibrosis: diagnostic and therapeutic challenges
por: McLean‐Tooke, Andrew, et al.
Publicado: (2019)

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events
por: Costabel, Ulrich, et al.
Publicado: (2014)

Diagnostic usefulness of bronchoscopy for peripheral pulmonary lesions in patients with idiopathic pulmonary fibrosis
por: Nogawa, Hitomi, et al.
Publicado: (2021)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study
por: Knarborg, Malene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iiqqtsrdd1o05lrfv72pma7lik